Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

PARSIPPANY, N.J.--(BUSINESS WIRE)--Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring its Portfolio Value and Industry Leadership

How does the market's reaction to similar recent M&A announcements in the biotech sector inform expectations for this deal? Will the acquisition trigger any changes in analyst coverage or target price revisions for both companies? What are the potential risks to the combined company's future growth and profitability?
Symbol: MNTX
Mergers
21 days ago
Read more businesswire

Verano Announces Resignation of Company President Darren Weiss

CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (ā€œVeranoā€ or the ā€œCompanyā€), a leading multi-state cannabis company, today announced the resignatio...

Could the news lead to increased volatility or a shortā€‘term price swing in VRNO stock? Will the resignation affect Verano's relationships with key partners, investors, or regulatory bodies? How does this leadership change compare to recent executive transitions at other cannabis companies?
Symbol: VRNO
Management
21 days ago
Read more globenewswire

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) a...

How might the current market sentiment (70) influence investor sentiment or trading volume in the short term? Is there any indication of changes in the company's cost structure or operating expenses that could affect margins? What does the guidance imply about IRWDā€™s cash flow and profitability outlook for the remainder of 2025?
Symbol: IRWD
Earnings
21 days ago
Read more businesswire

Appian Announces Second Quarter 2025 Financial Results

Appian (Nasdaq: APPN) today announced financial results for the second quarter ended June 30, 2025.

Are there any changes to the annual guidance or growth targets for the remainder of 2025? What is the valuation of APPN relative to similar companies in the BPM/low-code market? How does the margin profile (gross, operating, and net margins) evolve compared to prior quarters and peers?
Symbol: APPN
Earnings
21 days ago
Read more globenewswire

Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that i...

How might the Q2 earnings release influence the technical chart patterns and trading volume for CELC moving forward? Are there any regulatory or clinical trial milestones mentioned that could drive future price movements? What is the expected impact of the Q2 results on institutional and retail ownership trends for CELC?
Symbol: CELC
Earnings
21 days ago
Read more globenewswire

Cogentiq is now available in the new AWS Marketplace AI Agents and Tools category

NEW YORK, Aug. 7, 2025 /PRNewswire/ -- Fractal (www.fractal.ai), a global provider of artificial intelligence solutions to FortuneĀ® 500 companies, today announced the availability of Cogentiq in th...

Could this partnership impact Amazonā€™s future M&A or partnership strategy in the AI space? What is the expected timeline for revenue generation from Cogentiq after its launch on AWS Marketplace? How does this development compare to similar AI tools or agents recently launched on other cloud platforms?
Symbol: AMZN
Ai tools
21 days ago
Read more prnewswire

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights

RGX-202 in Duchenne muscular dystrophy on track for topline results 1H 2026 and BLA submission mid-2026 Pivotal trial enrollment accelerated, expected to complete in October 2025 ahead of previous ...

How might the market react to the company's ability to meet or exceed the accelerated timelines versus its previous guidance? What are the potential partnership or licensing opportunities that could arise from the successful development of RGXā€‘202 and RGXā€‘121? How does the current financial performance (e.g., net loss, R&D spend) compare to peers in the geneā€‘therapy space?
Symbol: RGX
Earnings
21 days ago
Read more prnewswire

Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSĀ® platform to develop in vivo gene editing ther...

What potential impact could these results and updates have on the stockā€™s valuation and price movement? Are there any competitive threats or market dynamics highlighted that could affect Precision BioSciences' positioning? What is the status of the ARCUSĀ® platform development and any upcoming milestones or trials?
Symbol: DTIL
Earnings
21 days ago
Read more businesswire

Backblaze Announces $10 Million Share Repurchase Program

SAN MATEO, Calif.--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE), the cloud storage innovator providing a modern alternative to traditional cloud providers, today announced that its Board of Dire...

What are the risks that the repurchase could deplete cash needed for growth initiatives or capital expenditures? How sensitive is the program to market conditionsā€”e.g., can the company pause or accelerate purchases if the share price moves sharply? What is the potential dilution effect of the employee stock purchase plan on existing shareholders, and how does the repurchase offset it?
Symbol: BLZE
Buyback
21 days ago
Read more businesswire